Leadership

John Alberico

President and Chief Executive Officer

John was the Managing Director of Inverness Medical Limited (“Inverness”) subsidiary in Scotland which manufactured the company’s glucose testing strips. During his 21-month tenure, he spearheaded efforts to increase the operation’s efficiency, building the capacity to cost-effectively produce over 1 billion test strips annually. He was also responsible for the transfer of the manufacturing of the company’s meter products to China.

Prior to Inverness, John was the Vice President of Operations for Bionostics Inc., a medical reagents and controls company, and the Vice President of Manufacturing for Nova Biomedical, a medical instrumentation company. John is also the founder of Medical Devices, Inc., an engineering consulting company specializing in the offshore contract manufacturing of high volume consumer medical devices. He holds a B.S. in Biomedical Engineering from Boston University.

K. Thomas Bailey

Chief Financial Officer and Treasurer

Tom Bailey joined the Company as Chief Financial Officer in March 2014. Prior to joining Agamatrix as CFO, Mr. Bailey served as President and CEO for Angiotech Pharmaceuticals Inc. until the fall of 2013, at which time he transitioned to Angiotech’s board. As CEO of Angiotech, Mr. Bailey led the company through a successful operational restructuring, and concluded the sale of one of Angiotech’s two medical device products businesses, generating significant returns for Angiotech’s shareholders. Prior to being named Angiotech’s CEO in the fall of 2011, Mr. Bailey served for six years as Angiotech’s CFO, and for two years as its Vice President, Business Development. Prior to Angiotech, Mr Bailey worked as an investment banker in the life sciences practice group at Credit Suisse First Boston and Donaldson, Lufkin & Jenrette.

Mr. Bailey currently serves as a member of the Board of Directors for Angiotech Pharmaceuticals, Inc. and LifeCare Management Services. He is a graduate of Harvard University, and also received his MBA from Harvard Business School.

David Olsen

Vice President, Quality Assurance, Regulatory and Clinical Affairs

Mr. Olsen joins AgaMatrix with 25 years of experience as a Regulatory Affairs & Quality professional in the IVD, Medical Devices, Biotechnology and Biologics environment. His extensive experience in new product development and licensure within the U.S., Canada, European Union, Brazil, India and China includes his most recent role at Harvard Apparatus Regenerative Technology, Inc., a Holliston, MA biotechnology company specializing in the development of cell based tracheal prostatic where he worked as Director of Regulatory Affairs, Clinical Affairs and Quality Assurance. Among his previous roles David served as Vice President, Corporate Regulatory & Quality for 5 years at SeraCare Life Sciences, Inc., a $60M IVD Biotechnology Company specializing in the manufacture of serological and nucleic acid controls and reference materials. Dave has also held executive and management positions with Defibtech, LLC, American Red Cross, and C.R. Bard, Inc. David earned his JD from the Massachusetts School of Law, his BS in Chemistry from Salem State University, and an LL.M. in Banking and Financial Law at Boston University School of Law.

John Alberico

Director, President and Chief Executive Officer

John was the Managing Director of Inverness Medical Limited (“Inverness”) subsidiary in Scotland which manufactured the company’s glucose testing strips. During his 21-month tenure, he spearheaded efforts to increase the operation’s efficiency, building the capacity to cost-effectively produce over 1 billion test strips annually. He was also responsible for the transfer of the manufacturing of the company’s meter products to China.

Prior to Inverness, John was the Vice President of Operations for Bionostics Inc., a medical reagents and controls company, and the Vice President of Manufacturing for Nova Biomedical, a medical instrumentation company. John is also the founder of Medical Devices, Inc., an engineering consulting company specializing in the offshore contract manufacturing of high volume consumer medical devices. He holds a B.S. in Biomedical Engineering from Boston University.

Carlos A. Ferrer

Director

Carlos A. Ferrer is a founding member of Ferrer Freeman & Company, LLC.Prior to creating FFC, Mr. Ferrer was a Managing Director at Credit Suisse First Boston. From 1982 through 1995, he developed and served as Head of CSFB’s Global Health Care Investment Banking Group. He is Vice Chairman of the Board of Trustees of the Cancer Research Institute, and a member of the Board of Directors of Ardent Health Services, LLC, GeneraMedix Pharmaceuticals Inc., OrthoRx, Inc., Preferred Care Partners Holding, Corp., and Viant Holdings, Inc. He graduated from Princeton University.

Dr. Paul Kelly

Director

Dr. Paul Kelly is Managing Director of Australian venture capital firm, OneVentures, and has held numerous executive positions in the biotechnology industry. Paul is currently Chair of Vaxxas Pty Ltd, Hatchtech Pty Ltd and non-executive director of Charm Health Pty Ltd.

Paul co-founded NASDAQ listed Gemini Genomics plc, which was acquired by Sequenom (Nasdaq: SQNM) in 2001 and led the restructuring of another listed US company, Orchid Cellmark (Nasdaq: ORCH), generating substantial returns and exits for investors. Dr Kelly led the seed financing of Agamatrix in 2002 and co-founded Mears Technologies Inc, a Boston based engineered materials company focused on the development and commercialization of products based on its proprietary electronic materials platform. In addition he has assisted and led a number of early-stage and mid stage companies achieve business results in order to attract funding and transform their ideas, technologies and products into sustainable successful businesses.

Jeffrey B. Kindler

Director

Jeff Kindler is a Director at AgaMatrix and a member of President Obama’s Management Advisory Board. Kindler was formerly the Chairman and Chief Executive Officer of Pfizer, the world’s largest research-based biopharmaceutical company, which he retired from in December 2010.

Kindler earned his BA in 1977 from Tufts University summa cum laude and his JD in 1980 from Harvard magna cum laude, where he was an editor of the Harvard Law Review. He also served as a law clerk to U.S. Supreme Court Justice William J. Brennan, Jr.

In 1990, Kindler joined the General Electric Company, where he was Vice President of Litigation and Legal Policy. In 1996, he joined McDonald’s Corporation as Executive Vice President and General Counsel, responsible for both legal and corporate affairs, and then moved into line management as President of Partner Brands, which included several restaurant brands such as Boston Market and Chipotle Mexican Grill.

Walter Winshall

Director

Walt is a principal in Collaborative Seed and Growth Partners, LLC, an investment firm specializing in the commercialization of early-stage technology. Previously, he was a co-founder and Chairman of SilverPlatter International, NV, a company providing information services for libraries, which was acquired by the Dutch publishing company Wolters Kluwer in 2001. He graduated from MIT in electrical engineering and from the Harvard Law School. At AgaMatrix, Walt provides guidance in corporate development strategy.